{"result": "(\"entity\"<|>ANTICUERPOS<|>ORGANIZATION<|>Anticuerpos are antibodies that can be transferred from mother to child, potentially causing congenital hypothyroidism.)\n##\n(\"entity\"<|>GLUCOSA<|>ORGANIZATION<|>Glucosa refers to glucose, a simple sugar that is essential for energy production in the body and is affected by thyroid hormones.)\n##\n(\"entity\"<|>T3<|>ORGANIZATION<|>T3, or triiodothyronine, is a thyroid hormone that plays a crucial role in metabolism and is often measured in thyroid function tests.)\n##\n(\"entity\"<|>T4<|>ORGANIZATION<|>T4, or thyroxine, is another thyroid hormone that is important for regulating metabolism and is commonly assessed in thyroid disorders.)\n##\n(\"entity\"<|>TSH<|>ORGANIZATION<|>TSH, or thyroid-stimulating hormone, is a hormone that regulates the production of thyroid hormones and is a key indicator in thyroid function tests.)\n##\n(\"entity\"<|>INTERFERÓN α<|>ORGANIZATION<|>Interferón α is a medication that can induce primary hypothyroidism as a side effect.)\n##\n(\"entity\"<|>DÉFICIT DE YODO<|>ORGANIZATION<|>Déficit de yodo refers to iodine deficiency, which is a known cause of hypothyroidism.)\n##\n(\"entity\"<|>HIPOTIROIDISMO<|>EVENT<|>Hipotiroidismo is a medical condition characterized by insufficient thyroid hormone production, leading to various metabolic issues.)\n##\n(\"relationship\"<|>ANTICUERPOS<|>HIPOTIROIDISMO<|>Anticuerpos can lead to congenital hypothyroidism when transferred from mother to child<|>6)\n##\n(\"relationship\"<|>T3<|>HIPOTIROIDISMO<|>T3 levels are typically low in patients with hypothyroidism, indicating thyroid dysfunction<|>8)\n##\n(\"relationship\"<|>T4<|>HIPOTIROIDISMO<|>T4 levels are also reduced in hypothyroidism, which is a key diagnostic criterion<|>8)\n##\n(\"relationship\"<|>TSH<|>HIPOTIROIDISMO<|>TSH levels are elevated in hypothyroidism as the body attempts to stimulate the thyroid gland<|>8)\n##\n(\"relationship\"<|>INTERFERÓN α<|>HIPOTIROIDISMO<|>Interferón α is known to cause primary hypothyroidism as a side effect<|>5)\n##\n(\"relationship\"<|>DÉFICIT DE YODO<|>HIPOTIROIDISMO<|>Iodine deficiency is a recognized cause of hypothyroidism<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: hormonas tiroideas, que explican entre el 10% y el 15% de los casos (opción B).                                                A. Los transportadores de glucosa sensibles a insulina (GLUT-4) están aumentados.\n               Una de las causas de hipotiroidismo congénito es la transferencia materna de anticuerpos                                                   B. El balance de nitrógeno es negativo.\n               bloqueantes del receptor de la TSH, aunque en este caso el hipotiroidismo es transitorio                                                   C. El hipotiroidismo condiciona tanto la elevación de colesterol como de triglicéridos.\n               (opción C).                                                                                                                                D.   La respuesta adrenérgica está aumentada y el input simpático está disminuido.\n               Referencias:\n               • Deladoey J, Ruel J, Giguere Y, Van Vliet G. Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective\n                 population-based study in Quebec. J Clin Endocrinol Metab. 2011;96:2422-9.                                                               COMENTARIO\n               • LaFranchi SH. Approach to the diagnosis and treatment of neonatal hypothyroidism. J Clin Endocrinol Metab. 2011;96:2959-67.\n               • Leger J, Olivieri A, Donaldson M. European Society for Paediatric Endocrinology Consensus Guidelines of screening, diagnosis and         Las hormonas tiroideas aumentan la expresión del transportador de glucosa sensible a\n                 treatment of congenital hypothyroidism. Horm Res Pediatr. 2014;81:80-103.                                                                insulina (GLUT 4), y se han comprobado niveles reducidos de este transportador en el hipo-\n               • Rodríguez A, Sanz M, Dulin E, Rodríguez-Arnao MD. Cribado neonatal en enfermedades endocrinológicas. Rev Esp Endocrinol Pediatr.\n                 2017;8(Suppl):47-61.                                                                                                                     tiroidismo (opción A falsa).\n                                                                                                                                                          Tanto la síntesis como la degradación de las proteínas están reducidas en el hipotiroidismo.\n         2     ¿Cuál de los fármacos siguientes no produce un hipotiroidismo primario?                                                                    Sin embargo, la degradación está disminuida en mayor grado, por lo que habitualmente se\n                                                                                                                                                          produce en el hipotiroidismo un balance nitrogenado ligeramente positivo (opción B falsa).\n               A. Litio.                                                                                                                                  Al igual que sucede con el metabolismo proteico, tanto la síntesis como la degradación de\n               B. Amiodarona.                                                                                                                             los lípidos está disminuida en el hipotiroidismo. Sin embargo, dado que la degradación se\n               C. Interferón α.                                                                                                                           encuentra disminuida en mayor grado que la síntesis, el efecto neto es un aumento de LDL\n               D.   Todas las respuestas son ciertas.                                                                                                     colesterol y de triglicéridos. Así pues, la opción C es verdadera.\n\n\n\n142                                                                                                                                                                                                                                                                                        143\n---\n                                                                                                                                                                                                                                                       TIROIDES                           3\n\n\n\n        Es conocido que las hormonas tiroideas aumentan la sensibilidad a las catecolaminas en                                                         En conjunto, los cambios que aparecen son una disminución marcada de la T3 libre, dismi-\n        una serie de tejidos como el muscular y el adiposo. En el hipotiroidismo hay una respuesta                                                     nución de la T4L y de la TSH, con aumento de los niveles de T3 reversa (opción A correcta).\n        reducida       del  AMPc      a  la adrenalina,      descrita en todos           los  pasos     del   proceso de señaliza-\n        ción de las catecolaminas, tanto a nivel del receptor como de posreceptor, lo que ocasiona                                                     Referencias:\n                                                                                                                                                       •  Salvatore D, Davies TF, Schlumberger M, Hay ID, Larsen PR. Thyroid Physiology and Diagnostic Evaluation of Patients with Thyroid\n        una disminución de la respuesta a las catecolaminas. Los pacientes hipotiroideos tienen                                                           Disorders. Cap. 11. 12.ª ed. Williams. Textbook of Endocrinology. p. 347.\n        sintomatología de estimulación adrenérgica disminuida, con una respuesta reducida a las\n        catecolaminas, particularmente a los efectos mediados por los receptores β1 y β2, si bien a\n        pesar de esta disminución de la respuesta adrenérgica el input simpático está paradójica-                                                   5  ¿Cuál de las siguientes no es una causa conocida de hipotiroidismo?\n        mente      aumentado (opción D falsa).                                                                                                         A.   lnterferón α.\n        Referencias:                                                                                                                                   B.   Déficit de yodo.\n        •  Liu YY, Brent GA. Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab.\n           2010;21:166-73.                                                                                                                             C. Hemangiomas hepáticos de gran tamaño.\n        •  Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M,\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>QUEBEC<|>GEO<|>Quebec is a province in Canada known for its healthcare studies, including research on congenital hypothyroidism.)\n##\n(\"entity\"<|>J CLIN ENDOCRINOL METAB<|>ORGANIZATION<|>J Clin Endocrinol Metab is a medical journal that publishes research related to endocrinology, including studies on congenital hypothyroidism.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY<|>ORGANIZATION<|>The European Society for Paediatric Endocrinology provides guidelines for the screening, diagnosis, and treatment of congenital hypothyroidism.)\n##\n(\"entity\"<|>SALVATORE D<|>PERSON<|>Salvatore D is an author of a textbook chapter on thyroid physiology and diagnostic evaluation of thyroid disorders.)\n##\n(\"entity\"<|>LIU YY<|>PERSON<|>Liu YY is a researcher who has contributed to studies on thyroid hormone signaling and metabolic regulation.)\n##\n(\"entity\"<|>HORM RES PEDIATR<|>ORGANIZATION<|>Horm Res Pediatr is a journal that publishes research on pediatric endocrinology, including studies on thyroid hormones.)\n##\n(\"relationship\"<|>QUEBEC<|>J CLIN ENDOCRINOL METAB<|>Quebec is the location of a study published in J Clin Endocrinol Metab regarding congenital hypothyroidism<|>7)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY<|>J CLIN ENDOCRINOL METAB<|>The European Society for Paediatric Endocrinology provides guidelines that are often referenced in J Clin Endocrinol Metab<|>6)\n##\n(\"relationship\"<|>SALVATORE D<|>HORM RES PEDIATR<|>Salvatore D has authored works that are published in Horm Res Pediatr, contributing to the field of pediatric endocrinology<|>8)\n##\n(\"relationship\"<|>LIU YY<|>HORM RES PEDIATR<|>Liu YY has conducted research that is relevant to the topics covered in Horm Res Pediatr<|>7)\n<|COMPLETE|>"}]}